Merck & Co., Inc. 6MK.F Stock
Merck & Co., Inc. Price Chart
Merck & Co., Inc. 6MK.F Financial and Trading Overview
| Merck & Co., Inc. stock price | 118.2 EUR |
| Previous Close | 100 EUR |
| Open | 99.6 EUR |
| Bid | 99.4 EUR x 100000 |
| Ask | 100.4 EUR x 100000 |
| Day's Range | 99.3 - 99.6 EUR |
| 52 Week Range | 80.3 - 108.8 EUR |
| Volume | 190 EUR |
| Avg. Volume | 439 EUR |
| Market Cap | 251.97B EUR |
| Beta (5Y Monthly) | 0.357746 |
| PE Ratio (TTM) | 20.993658 |
| EPS (TTM) | 0.13 EUR |
| Forward Dividend & Yield | 2.7 (2.65%) |
| Ex-Dividend Date | June 14, 2023 |
| 1y Target Est | N/A |
6MK.F Valuation Measures
| Enterprise Value | 277.73B EUR |
| Trailing P/E | 20.993658 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.3541064 |
| Price/Book (mrq) | 5.3800726 |
| Enterprise Value/Revenue | 4.799 |
| Enterprise Value/EBITDA | 12.417 |
Trading Information
Merck & Co., Inc. Stock Price History
| Beta (5Y Monthly) | 0.357746 |
| 52-Week Change | 26.27% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 108.8 EUR |
| 52 Week Low | 80.3 EUR |
| 50-Day Moving Average | 103.82 EUR |
| 200-Day Moving Average | 99.62 EUR |
6MK.F Share Statistics
| Avg. Volume (3 month) | 439 EUR |
| Avg. Daily Volume (10-Days) | 475 EUR |
| Shares Outstanding | 2.54B |
| Float | 2.53B |
| Short Ratio | N/A |
| % Held by Insiders | 0.088% |
| % Held by Institutions | 77.43% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.8 |
| Trailing Annual Dividend Yield | 2.79% |
| 5 Year Average Dividend Yield | 289.00% |
| Payout Ratio | 0.5547 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 22.51% |
| Operating Margin (ttm) | 32.31% |
| Gross Margin | 72.75% |
| EBITDA Margin | 38.65% |
Management Effectiveness
| Return on Assets (ttm) | 10.89% |
| Return on Equity (ttm) | 29.69% |
Income Statement
| Revenue (ttm) | 57.87B EUR |
| Revenue Per Share (ttm) | 22.83 EUR |
| Quarterly Revenue Growth (yoy) | -8.90% |
| Gross Profit (ttm) | 42.08B EUR |
| EBITDA | 22.37B EUR |
| Net Income Avi to Common (ttm) | 13.03B EUR |
| Diluted EPS (ttm) | 4.73 |
| Quarterly Earnings Growth (yoy) | -34.50% |
Balance Sheet
| Total Cash (mrq) | 10.39B EUR |
| Total Cash Per Share (mrq) | 4.09 EUR |
| Total Debt (mrq) | 30.75B EUR |
| Total Debt/Equity (mrq) | 65.55 EUR |
| Current Ratio (mrq) | 1.444 |
| Book Value Per Share (mrq) | 18.457 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 15.67B EUR |
| Levered Free Cash Flow (ttm) | 9.5B EUR |
Profile of Merck & Co., Inc.
| Country | Germany |
| State | NJ |
| City | Rahway |
| Address | 126 East Lincoln Avenue |
| ZIP | 07065 |
| Phone | 908 740 4000 |
| Website | https://www.merck.com |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | 67000 |
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Q&A For Merck & Co., Inc. Stock
What is a current 6MK.F stock price?
Merck & Co., Inc. 6MK.F stock price today per share is 118.2 EUR.
How to purchase Merck & Co., Inc. stock?
You can buy 6MK.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Merck & Co., Inc.?
The stock symbol or ticker of Merck & Co., Inc. is 6MK.F.
Which industry does the Merck & Co., Inc. company belong to?
The Merck & Co., Inc. industry is Drug Manufacturers-General.
How many shares does Merck & Co., Inc. have in circulation?
The max supply of Merck & Co., Inc. shares is 2.53B.
What is Merck & Co., Inc. Price to Earnings Ratio (PE Ratio)?
Merck & Co., Inc. PE Ratio is 909.23080000 now.
What was Merck & Co., Inc. earnings per share over the trailing 12 months (TTM)?
Merck & Co., Inc. EPS is 0.13 EUR over the trailing 12 months.
Which sector does the Merck & Co., Inc. company belong to?
The Merck & Co., Inc. sector is Healthcare.